SCHEMBL31301510

SCHEMBL31301510

CON(C)C(=O)c1ncc(-c2ccc(Cl)cc2)o1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.45
NOTUM Q6P988 1/20 0.44
HDAC6 Q9UBN7 6/20 0.44
HDAC1 Q13547 5/20 0.44
RAB9A P51151 2/20 0.41
PKM P14618 1/20 0.41
NPC1 O15118 1/20 0.40
VCP P55072 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
FAAH O00519 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31301507 0.82 GPBAR1 (0.49) MAP4K4NOTUMHDAC6HDAC1RAB9A
SCHEMBL31301485 0.78 GPBAR1 (0.54) MAP4K4NOTUMHDAC6HDAC1RAB9A
SCHEMBL31301378 0.78 GPBAR1 (0.54) MAP4K4NOTUMHDAC6HDAC1RAB9A
SCHEMBL31301383 0.76 MAP4K4 (0.43) MAP4K4NOTUMHDAC6HDAC1RAB9A
SCHEMBL31301334 0.76 NOTUM (0.54) MAP4K4NOTUMHDAC6HDAC1RAB9A
SCHEMBL31301390 0.76 GPBAR1 (0.44) MAP4K4NOTUMHDAC6HDAC1HDAC3
SCHEMBL31301357 0.75 MAPKAPK2 (0.45) MAP4K4NOTUMHDAC6HDAC1SMN1; SMN2
SCHEMBL31301514 0.74 GPBAR1 (0.56) MAP4K4NOTUMHDAC6HDAC1GPBAR1
SCHEMBL31301564 0.74 TARBP2 (0.53) MAP4K4NOTUMHDAC6HDAC1RAB9A
SCHEMBL30301357 0.74 MAP4K4 (0.58) MAP4K4NOTUMHDAC6HDAC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727549-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIV GEORGIA (US) 2026-04-09 US disclosed
WO-2024258900-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2024-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS SUB1, PFN1, HCCS MAP4K4 4387/4885NOTUM 3845/4885HDAC6 1649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.